As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

Smallcap valuations seem high but underlying fundamentals have improved. Aditya Khemani of Invesco Mutual Fund sees this as a structural sh...

Delius Pharmaceuticals has secured approval from the CDSCO to import Ceftriaxone Sodium API from China's Guangxi Kelun Pharmaceutical. This...

The Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...

The Competition Commission of India has approved Mankind Pharma's Rs 13,630 crore acquisition of Bharat Serums and Vaccines. This acquisiti...

Scimplify to use the fresh capital to enhance research and development (R&D) capabilities and enter new markets. According to the company t...

Production-Linked Incentive (PLI) scheme is projected to draw investments worth Rs 3-4 lakh crore over four years, creating 2 lakh jobs. Ic...

Aquapharm is a specialty chemical manufacturer and offers a range of products from phosphonates to pharmaceutical intermediaries. It deals ...

In a tweet on Friday, the watchdog said it has approved acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures as ...

Commerce and Industry Minister Piyush Goyal said that the closure of factories in China may affect Indian industries, which import componen...

GV Prasad, Chairman, CII National Committee on Pharmaceuticals said that everybody should up their game in terms of quality, systems, disci...

At least 7-8 officials from the US administration, including assistant US trade representative Mark Linscott, will be in New Delhi for the ...

As per the contract, the company will supply high value agro-chemical intermediary for use in herbicides over a period of 10 years.

The proposed park will have components and related activities with regard to antibiotics, synthetic drugs, vitamins, vaccines, drug formula...

TSIIC shall send detailed project proposal (DPR) to the government on modalities for implementation and execution of project.

Watch how Prashant Tandon and Sameer Maheshwari started HealthKart and the startup's plans to raise Series C funding to propel growth.

Solvay Pharmaceuticals BV the $11bn pharmaceutical major has consistently increased its sourcing from the Ahmedabad-based Dishman Pharmaceu...